`571.272.7822
`
`
`
`
`
`
`
`
`
`
`
` Paper 72
`
`
` Entered: September 17, 2021
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`
`
`
`BEFORE THE OFFICE OF THE UNDERSECRETARY AND DIRECTOR OF
`THE UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`GALDERMA S.A.; GALDERMA LABORATORIES, INC.;GALDERMA
`LABORATORIES LP; GALDERMA RESEARCH & DEVELOPMENT SNC;
`NESTLÉ SKIN HEALTH, INC.; NESTLÉ SKIN HEALTH S.A.; and
`NESTLÉ S.A.,
`Petitioner,
`
`v.
`
`MEDY-TOX, INC.,
`Patent Owner.
`____________
`
`PGR2019-00062
`Patent 10,143,728 B2
`____________
`
`
`
`Before ANDREW HIRSHFELD, Commissioner for Patents, Performing the
`Functions and Duties of the Under Secretary of Commerce for Intellectual
`Property and Director of the United States Patent and Trademark Office.
`
`
`
`
`ORDER
`
`
`
`
`
`PGR2019-00062
`Patent 10,143,728 B2
`
`
`The Office has received a request for Director review of the Final Written
`Decision in this case. See Ex. 3100. The request was referred to Mr. Hirshfeld,
`Commissioner for Patents, Performing the Functions and Duties of the Under
`Secretary of Commerce for Intellectual Property and Director of the United States
`Patent and Trademark Office.
`It is ORDERED that the request for Director review is denied; and
`FURTHER ORDERED that the Patent Trial and Appeal Board’s Final
`Written Decision in this case is the final decision of the agency.
`
`
`
`
`
`
`
`2
`
`
`
`PGR2019-00062
`Patent 10,143,728 B2
`
`For PETITIONER:
`
`Joseph Mahoney
`Amanda Bonner
`Erick Palmer
`MAYER BROWN LLP
`jmahoney@mayerbrown.com
`astreff@mayerbrown.com
`ejpalmer@mayerbrown.com
`
`For PATENT OWNER:
`
`Vishal Gupta
`John Molenda
`STEPTOE & JOHNSON LLP
`vgupta@steptoe.com
`jmolenda@steptoe.com
`
`Dominick Conde
`VENABLE LLP
`dconde@venable.com
`
`
`
`
`
`
`3
`
`